Mama, Jane Zainab .
HRN: 22-00-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/01/2022
10/07/2022
IV
70mg
OD
PCAP-C; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes